EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.1.50 | transient functional expression in COS-1 cells, stable functional expression in PC-3 cells and in LNCaP cells | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.50 | NADPH | strong inhibition of 3alpha-androstanediol oxidation | Homo sapiens | |
1.1.1.270 | NADPH | the NAD+:NADPH ratio in cell will determinewhether AKR1C2 makes 5alpha-dihydrotestosterone | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.50 | 0.022 | - |
(2Z)-2-(5-hydroxy-4,6-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N,N-di(prop-2-en-1-yl)hydrazinecarbothioamide | pH 7.0, 37°C with NADP+ | Homo sapiens | |
1.1.1.50 | 0.026 | - |
5alpha-dihydrotestosterone | pH 7.0, 37°C, with NAD(P)H | Homo sapiens | |
1.1.1.50 | 0.042 | - |
(2Z)-2-(5-hydroxy-4,6-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N,N-di(prop-2-en-1-yl)hydrazinecarbothioamide | pH 7.0, 37°C with NAD+ | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.50 | 5alpha-dihydrotestosterone + NADH | Homo sapiens | reaction direction is regulated by the NAD+:NADPH relation in the cell | 3alpha-androstanediol + NAD+ | - |
r | |
1.1.1.270 | 5alpha-dihydrotestosterone + NADPH + H+ | Homo sapiens | in prostate cells AKR1C2 acts as a 3-ketosteroid reductase to eliminate 5alpha-dihydrotestosterone and prevents activation of androgen receptor. AKR1C2 does not act as an oxidase due to either potent product inhibition by NADPH or because it cannot surmount the oxidative 17beta-hydroxysteroid dehydrogenase present. AKR1C2 is not a source of 5alpha-dihydrotestosterone in PC-3 cells | 5alpha-androstan-3alpha,17beta-diol + NADP+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.50 | Homo sapiens | - |
type 3 isozyme AKR1C2 | - |
1.1.1.270 | Homo sapiens | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.50 | prostate | - |
Homo sapiens | - |
1.1.1.270 | PC-3 cell | AKR1C2 is not a source of 5alpha-dihydrotestosterone in PC-3 cells | Homo sapiens | - |
1.1.1.270 | prostate | in primary cultures of epithelial cells, high levels of AKR1C2 transcripts are detected in prostate cancer, but not in cell from normal prostate. In prostate cells AKR1C2 acts as a 3-ketosteroid reductase to eliminate 5alpha-dihydrotestosterone and prevents activation of androgen receptor | Homo sapiens | - |
1.1.1.270 | prostate cancer cell | in primary cultures of epithelial cells, high levels of AKR1C2 transcripts are detected in prostate cancer, but not in cell from normal prostate | Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
1.1.1.50 | additional information | - |
- |
Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.50 | (2Z)-2-(5-hydroxy-4,6-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N,N-di(prop-2-en-1-yl)hydrazinecarbothioamide + NAD+ | - |
Homo sapiens | ? | - |
r | |
1.1.1.50 | (2Z)-2-(5-hydroxy-4,6-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N,N-di(prop-2-en-1-yl)hydrazinecarbothioamide + NADP+ | - |
Homo sapiens | ? | - |
r | |
1.1.1.50 | 3alpha-androstanediol + NAD+ | oxidation utilizing NAD+ as a cofactor is the preferred reaction in vitro | Homo sapiens | 5alpha-dihydrotestosterone + NADH | - |
r | |
1.1.1.50 | 5alpha-dihydrotestosterone + NADH | reaction direction is regulated by the NAD+:NADPH relation in the cell | Homo sapiens | 3alpha-androstanediol + NAD+ | - |
r | |
1.1.1.270 | 3alpha-androstanediol + NAD+ | - |
Homo sapiens | 5alpha-dihydrotestosterone + NADH | - |
? | |
1.1.1.270 | 5alpha-dihydrotestosterone + NADPH + H+ | - |
Homo sapiens | 5alpha-androstan-3alpha,17beta-diol + NADP+ | - |
? | |
1.1.1.270 | 5alpha-dihydrotestosterone + NADPH + H+ | in prostate cells AKR1C2 acts as a 3-ketosteroid reductase to eliminate 5alpha-dihydrotestosterone and prevents activation of androgen receptor. AKR1C2 does not act as an oxidase due to either potent product inhibition by NADPH or because it cannot surmount the oxidative 17beta-hydroxysteroid dehydrogenase present. AKR1C2 is not a source of 5alpha-dihydrotestosterone in PC-3 cells | Homo sapiens | 5alpha-androstan-3alpha,17beta-diol + NADP+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.50 | 3alpha-hydroxysteroid dehydrogenase | - |
Homo sapiens |
1.1.1.50 | AKR1C2 | - |
Homo sapiens |
1.1.1.50 | aldo-keto reductase 1C2 | - |
Homo sapiens |
1.1.1.50 | More | enzyme belongs to the AKR1C subfamily of the AKR superfamily of enzymes | Homo sapiens |
1.1.1.270 | AKR1C2 | - |
Homo sapiens |
1.1.1.270 | aldo-keto reductase 1C2 | - |
Homo sapiens |
1.1.1.270 | type 3 3alpha-hydroxysteroid dehydrogenase | - |
Homo sapiens |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
1.1.1.50 | 37 | - |
assay at | Homo sapiens |
EC Number | Turnover Number Minimum [1/s] | Turnover Number Maximum [1/s] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.50 | 0.0038 | - |
5alpha-dihydrotestosterone | pH 7.0, 37°C, with NAD(P)H | Homo sapiens | |
1.1.1.50 | 0.004 | - |
(2Z)-2-(5-hydroxy-4,6-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N,N-di(prop-2-en-1-yl)hydrazinecarbothioamide | pH 7.0, 37°C with NADP+ | Homo sapiens | |
1.1.1.50 | 0.0167 | - |
(2Z)-2-(5-hydroxy-4,6-dimethyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)-N,N-di(prop-2-en-1-yl)hydrazinecarbothioamide | pH 7.0, 37°C with NAD+ | Homo sapiens |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
1.1.1.50 | 7 | - |
assay at | Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.50 | NAD+ | oxidation utilizing NAD+ as a cofactor is the preferred reaction in vitro | Homo sapiens | |
1.1.1.50 | NADH | - |
Homo sapiens | |
1.1.1.50 | NADP+ | - |
Homo sapiens | |
1.1.1.50 | NADPH | - |
Homo sapiens | |
1.1.1.270 | NADPH | - |
Homo sapiens |